US Stock MarketDetailed Quotes

KPHMW KIORA PHARMACEUTICALS INC C/WTS 27/09/2027 (TO PUR COM)

Watchlist
  • 0.020
  • 0.0000.00%
15min DelayClose Aug 8 16:00 ET
0Market Cap0.00P/E (TTM)

About KIORA PHARMACEUTICALS INC C/WTS 27/09/2027 (TO PUR COM) Company

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Company Profile

SymbolKPHMW
Company NameKIORA PHARMACEUTICALS INC C/WTS 27/09/2027 (TO PUR COM)
Listing DateFeb 13, 2015
Founded1998
CEOMr. Brian M. Strem, PhD
MarketPink Market
Employees12
Fiscal Year Ends12-31
Address332 Encinitas Boulevard,Suite 102
CityEncinitas
ProvinceCalifornia
CountryUnited States of America
Zip Code92024
Phone1-858-224-9600

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian M. Strem, PhD
  • Director, President and Chief Executive Officer
  • 802.27K
  • Melissa Tosca, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 387.48K
  • Eric J. Daniels
  • Chief Development Officer
  • 652.31K
  • Dr. Praveen Tyle, PhD
  • Chairman of the Board
  • 98.25K
  • Aron Shapiro
  • Director
  • 70.12K
  • Carmine Stengone
  • Independent Director
  • 24.58K
  • Lisa Walters Hoffert
  • Independent Director
  • --
  • Erin Parsons
  • Independent Director
  • 84.50K
  • Dr. David A. Hollander, M.D.
  • Independent Director
  • 77.62K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.